Cornwall's main hospital will get two next-generation radiotherapy machines within 12 months, after being awarded £2.6 ...

Schultz and the rest of the APL team, including lead scientists Alan Hunt, Tom McJunkin and Tom Haard, have demonstrated that the linear accelerator can be used to simulate not only cosmic rays but ...

The U.S. Food and Drug Administration (FDA) has given Xellsmart Biopharmaceutical the go-ahead to start a Phase 1 clinical trial testing its stem cell-based therapy XS-228 in people with amyotrophic ...